Lang & Schwarz
23.12.24
22:58 Uhr
0,028 Euro
0,000
0,00 %
0,00 %
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,022 | 0,034 | 23.12. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 17.12. | Stagezero Life Sciences Ltd (2): Stagezero loses $1.43-million (U.S.) in nine months | 3 | Stockwatch | ||
| 16.12. | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Q3 2024 Financial Results and Operational Update | 1 | TheNewswire | ||
| 01.10. | StageZero Life Sciences Ltd.: StageZero Life Sciences, Ltd Announces Q2 2024 Financial Results and Operational Update | 5 | TheNewswire | ||
| 09.07. | Stagezero Life Sciences Ltd (2): Stagezero working on filing 2023 results by July 8 | 1 | Stockwatch | ||
| 09.07. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials Under the Failure To File Cease Trade Order | 613 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / July 9, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
| STAGEZERO LIFE SCIENCES Aktie jetzt für 0€ handeln | |||||
| 04.07. | Stagezero Life Sciences Ltd (2): Stagezero has no material changes | 1 | Stockwatch | ||
| 04.07. | Stagezero Life Sciences Ltd (2): Stagezero Life has no material changes | 1 | Stockwatch | ||
| 04.07. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Filing of Full Year 2023 Financials under the Failure to File Cease Trade Order | 394 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / July 3, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTC PINK:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA gene... ► Artikel lesen | |
| 23.05. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Update on Failure to File Cease Trade Order | 529 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / May 23, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
| 17.05. | StageZero Life Sciences Ltd: StageZero Life Sciences, Ltd Announces Q1 2024 Financial Results and Operational Update | 1.324 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / May 17, 2024 / StageZero Life Sciences ("StageZero" or the "Company") (TSX:SZLS), an integrated healthcare company with the first and only mRNA multi-cancer diagnostic for... ► Artikel lesen | |
| 10.04. | XFRA 61N1: AUSSETZUNG/SUSPENSION | 233 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILSTAGEZERO LIFE SCIENC.... ► Artikel lesen | |
| 05.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Provides an Update on Application for Management Cease Trade Order | 491 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 5, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen | |
| 03.04. | StageZero Life Sciences Ltd: StageZero Life Sciences Announces Delay to Fourth Quarter and Year End 2023 Financial Results | 429 | ACCESSWIRE | TORONTO, ON / ACCESSWIRE / April 2, 2024 / StageZero Life Sciences, Ltd. (TSX:SZLS)(OTCQB:SZLSF) ("StageZero" or the "Company"), an integrated healthcare company with the first and only mRNA multi-cancer... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 46,380 | +1,27 % | Carl Zeiss Meditec-Aktie leicht im Minus (45,54 €) | Das Wertpapier von Carl Zeiss Meditec notiert am Freitag ein wenig leichter. Das Papier kostete zuletzt 45,54 Euro. Der Anteilsschein von Carl Zeiss Meditec verzeichnet zur Stunde einen Kursrückgang... ► Artikel lesen | |
| INTUITIVE SURGICAL | 506,80 | +0,06 % | Intuitive Surgical Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | ||
| BOSTON SCIENTIFIC | 86,50 | 0,00 % | Boston Scientific, Stryker, UnitedHealth: Diese Aktien profitieren vom demografischen Wandel | Altwerden - idealerweise bei bester Gesundheit - wollen wir alle. Doch die zunehmende Überalterung der Bevölkerung hat zwei Seiten. Zum einen belastet sie das Gesundheits-, Pflege- und Rentensystem... ► Artikel lesen | |
| PLUS THERAPEUTICS | 1,050 | +13,51 % | Plus Therapeutics Announces Renewal Of Master Services Agreement With Telix | CANBERA (dpa-AFX) - Plus Therapeutics (PSTV) announced the renewal of its Master Services Agreement with Telix IsoTherapeutics Group. The MSA secures supply of cGMP Re-186, the radioisotope... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,015 | -18,28 % | Mountain Valley MD Holdings Inc: Mountain Valley MD talks Quicksome manufacturing work | ||
| ASENSUS SURGICAL | 0,305 | 0,00 % | KARL STORZ akquiriert den US-amerikanischen Robotik-Spezialisten Asensus Surgical | Tuttlingen / Research Triangle Park, USA (ots) - Das familiengeführte und international agierende Medizintechnikunternehmen KARL STORZ gibt die Akquisition des innovativen Robotik-Spezialisten Asensus... ► Artikel lesen | |
| MEDIVOLVE | 0,003 | 0,00 % | Medivolve Inc (2): Medivolve president, CEO Preiner resigns | ||
| EMPOWER CLINICS | - | - | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 30.07.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 30.07.2024Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 30.07.2024ISIN NameCA29246V2030 EMPOWER... ► Artikel lesen | |
| LIFEWARD | 1,710 | +14,77 % | Lifeward Ltd. Reports Third Quarter 2024 Financial Results | Second consecutive quarter of 20 ReWalk systems sold Robust growth in U.S. ReWalk pipeline of approximately 70 qualified leads for potential claim submission with Medicare and other U.S. payors ... ► Artikel lesen | |
| SENSEONICS | 0,450 | -0,53 % | Senseonics Holdings, Inc.: Eversense 365 Receives FDA Clearance: The World's First One Year CGM | Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes With a single sensor, the Eversense 365 system provides one year of use, versus... ► Artikel lesen | |
| EKSO BIONICS | 0,570 | 0,00 % | Ekso Bionics Holdings, Inc.: Ekso Bionics Announces Third Quarter 2024 Financial Results | SAN RAFAEL, Calif., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (Nasdaq: EKSO) (the "Company"), an industry leader in exoskeleton technology for medical and industrial use, today... ► Artikel lesen | |
| IMUNON | 0,780 | +6,85 % | Imunon, Inc.: IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer | Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable future... ► Artikel lesen | |
| ROCKWELL MEDICAL | 1,977 | +1,65 % | Rockwell Medical (NASDAQ:RMTI) Earns "Buy" Rating from HC Wainwright | ||
| AVINGER | 1,280 | -11,72 % | Avinger Inc - 8-K, Current Report | ||
| VIRIDIAN THERAPEUTICS | 18,000 | -2,17 % | Viridian Therapeutics (NASDAQ:VRDN) Shares Gap Down - Time to Sell? |
STAGEZERO LIFE SCIENCES LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,028 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu STAGEZERO LIFE SCIENCES LTD finden Sie auf Wallstreet Online.
